Article Sidebar
Views PDF: 0
RESULTS OF BLOOD GLUCOSE CONTROL AND SOME RELATED FACTORS IN PATIENTS WITH NEW-ONSET DIABETES MELLITUS AFTER KIDNEY TRANSPLANTATION
Main Article Content
Abstract
SUMMARY
Objective: To survey the results of blood glucose control and some related factors in patients with onset diabetes after kidney transplantation. Subjects and methods: Conducted a cross-sectional study on 118 patients diagnosed with onset diabetes after kidney transplant with average age: 46.59 ± 10.26 years old, male: female ratio was 2:1. All patients had their fasting blood glucose measured, identifying a number of related factors including: hypertension, dyslipidemia. Results: 86.44% of patients achieved target blood glucose control, 70.34% met HbA1c target. The rate of patients controlling total cholesterol reaching the target is 57.6%%, TG is 52.5%, LDL-C is 78.8%, HDL-C is 29.67%. BP control reached the target of 36.93%. Controlling all three factors HbA1c, LDL-C and blood pressure reached the treatment target of 8.5%. Conclusion: The results of blood glucose control and some related factors are not good.
Article Details
Keywords
New onset diabetes mellitus after kidney transplantation, blood glucose,, blood glucose, hypertension, dyslipidemia
References
2. Lê Quang Toàn, Hoàng Thu Trang. Khảo sát thực trạng lựa chọn thuốc hạ glucose máu ở các bệnh nhân đái tháo đường típ 2 mới phát hiện tại Bệnh viện Nội tiết Trung ương. Tạp chí Nội tiết - Đái tháo đường Việt Nam. 2022. 50:178-185. DOI:https://doi.org/ 10.47122/ vjde. 2021.50.21.
3. Nguyễn Văn Tuyến và Nguyễn Khoa Diệu Vân. Thực trạng kiểm soát đường huyết và các yếu tố nguy cơ trên bệnh nhân đái tháo đường típ 2 điều trị ngoại trú tại bệnh viện gang thép Thái Nguyên. Tạp chí Nội tiết - Đái tháo đường Việt Nam. 2018:1 -13.
4. Phạm Vũ Thụy. Nghiên cứu nồng độ adiponectin, leptin huyết tương và mối liên quan với lâm sàng, cận lâm sàng ở người bệnh đái tháo đường mới mắc sau ghép thận. Luận án Tiến sĩ Y học, Học viện Quân y. 2023.
5. Kong DCC, Akbari A, Malcolm J, et al. Determinants of poor glycemie control in patients with kidney transplants: A single-center retrospective cohort study in Canada. Can J Kidney Health Dis. 2020; 7:2054358120922628.
6. Khunti K, Ceriello A, Cos X, De Block c. Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis. Diabetes Res Clin Tract. 2018 Mar; 137:137-148. DOI: 10.1016/j.diabres.2017.12.004.
7. Yang X, Liu Q, Fan Y, et al. Cardiovascular risk factor status in hospitalized patients with type 2 diabetes in China. Front Endocrinol (Lausanne). 2021 Jul 22; 12:664183. DOI: 10.3389/fendo.2021.664183. PMID: 34367063.
8. Sanyal D, Biswas M, Chaudhari N. Long-term efficacy and safety of anti-hyperglycaemic agents in new onset diabetes after transplant: Results from outpatient-based 1-year follow-up and a brief review of treatment options. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021; 15:13e19.
9. Safai N, Carstensen B, Vestergaard H, Ridderstrale M. Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: A retrospective cohort study from a specialised diabetes centre in Denmark. BMJ Open. 2018 Mar 17; 8(3):eO19214. DOI: 10.1136/ bmjopen-2017-019214.
10. Chen R, Ji L, Chen L, et al. Glycemic control rate of T2DM outpatients in China: A multi-center survey. Med Sci Monit. 2015 May 19; 21:1440-1446. DOI: 10.12659/MSM. 892246.